Strategic partnership Medocity has a recent strategic partnership with Globant to accelerate digitalization of clinical research, indicating openness to collaborations with large technology services firms and potential co-sell opportunities.

Digital health platform The company offers an AI-driven, enterprise-level digital care ecosystem for chronic conditions, suggesting upsell potential to healthcare systems and pharma sponsors seeking comprehensive digital health solutions and scalable patient engagement.

Regulatory readiness Medocity has engaged third-party HITRUST and SOC assessments via 360 Advanced, signaling a focus on regulatory compliance and data security that can facilitate selling to regulated healthcare clients and insurers.

Healthcare partnerships Past collaborations with Cigna for COVID-19 self-support and connected care demonstrate appetite for payer and insurer partnerships, presenting a channel for expanding digital patient support programs.

Growth signals Revenue range and a funding backdrop of substantial backing (tens of millions in funding) position Medocity as a growing vendor in health IT services, with potential for expanded deployments, clinical trial solutions, and RPM-related offerings to life sciences customers.